Beyond the new normal: Assessing the feasibility of vaccine-based suppression of SARS-CoV-2

• Madison Stoddard ,

  Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

  * E-mail: madison.stoddard@fractaltx.com

  Affiliation Fractal Therapeutics, Cambridge, MA, United States of America

  https://orcid.org/0000-0001-9853-8500

  ⨯
• Sharanya Sarkar,

  Roles Data curation, Writing – review & editing

  Affiliation Department of Microbiology and Immunology, Dartmouth College, Hanover, NH, United States of America

  ⨯
• Lin Yuan,

  Roles Writing – review & editing

  Affiliation Fractal Therapeutics, Cambridge, MA, United States of America

  ⨯
• Ryan P. Nolan,

  Roles Conceptualization, Writing – review & editing

  Affiliation Halozyme Therapeutics, San Diego, CA, United States of America

  ⨯
• Douglas E. White,

  Roles Conceptualization, Writing – review & editing

  Affiliation Independent Researcher, United States of America

  ⨯
• Laura F. White,

  Roles Writing – review & editing

  Affiliation Department of Biostatistics, Boston University, Boston, MA, United States of America

  https://orcid.org/0000-0002-0588-8235

  ⨯
• Natasha S. Hochberg,

  Roles Conceptualization, Writing – review & editing

  Affiliations Department of Epidemiology, Boston University School of Public Health, Boston, MA, United States of America, Department of Medicine, Boston University School of Medicine, Boston, MA, United States of America, Boston Medical Center, Boston, MA, United States of America

  ⨯
• Arijit Chakravarty

  Roles Conceptualization, Supervision, Writing – original draft, Writing – review & editing

  Affiliation Fractal Therapeutics, Cambridge, MA, United States of America

  ⨯